Bellerophon Therapeutics, Inc.·4

May 19, 4:04 PM ET

Bellerophon Therapeutics, Inc. 4

4 · Bellerophon Therapeutics, Inc. · Filed May 19, 2017

Insider Transaction Report

Form 4
Period: 2017-05-17
Schoeps Megan
Principal Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2017-05-17$1.40/sh10,459$14,68318,248 total

Documents

1 file
  • 4
    wf-form4_149522428320187.xmlPrimary

    FORM 4